Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Free Radical Level in SCC of Tongue Patients Tumor, Serum and Saliva

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2007 by Sheba Medical Center.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Sheba Medical Center
ClinicalTrials.gov Identifier:
NCT00426062
First received: January 23, 2007
Last updated: February 18, 2007
Last verified: February 2007
  Purpose

Study comparing level of free radicals in tumor tissue, blood serum and saliva in patients with Squamous Cell Carcinoma of tongue and mouth floor. Patients with benign fibroma of oral cavity and normal gingiva around extracted lower wisdom tooth are used for control


Condition Phase
Squamous Cell Carcinoma
Phase 1

Study Type: Observational
Study Design: Observational Model: Defined Population
Time Perspective: Longitudinal

Resource links provided by NLM:


Further study details as provided by Sheba Medical Center:

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

  1. Older than 18 years of age.
  2. Mentally healthy
  3. SCC of Tongue or Mouth Floor
  4. Benign Fibroma of Oral Cavity
  5. Lower wisdom tooth extraction -

Exclusion Criteria:

  1. Younger than 18 years of age
  2. Mentally incapacitated
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00426062

Contacts
Contact: Alex Dobriyan, DMD 972-3-6040306 lancet72@gmail.com
Contact: Ran Yahalom, DMD 972-3-5303819 ranyahalom@gmail.com

Locations
Israel
Sheba Medical Center Recruiting
Ramat Gan, Israel, 52621
Sponsors and Collaborators
Sheba Medical Center
Investigators
Principal Investigator: Alex Dobriyan, DMD Sheba Medical Center
Principal Investigator: Ran Yahalom, DMD Sheba Medical Center
Principal Investigator: Rafi Nagler, DMD,MD Rambam Health Care Campus
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00426062     History of Changes
Other Study ID Numbers: SHEBA-06-4116-AD-CTIL
Study First Received: January 23, 2007
Last Updated: February 18, 2007
Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration

Keywords provided by Sheba Medical Center:
Squamous Cell Carcinoma of Tongue and mouth floor

Additional relevant MeSH terms:
Carcinoma
Carcinoma, Squamous Cell
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Glandular and Epithelial
Neoplasms, Squamous Cell

ClinicalTrials.gov processed this record on November 19, 2014